DOI:
10.1055/s-00000066
RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren
LinksClose Window
References
Rosell R, Carcereny E, Gervais R. et al.
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial.
The Lancet Oncology 2012;
13: 239-246
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.